Past Dengue Infection Appears to Protect Children from Zika Symptoms

Children were 38 percent less likely to show signs of Zika infection if they had previously had dengue.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Zika virus particles (red) shown in African green monkey kidney cells
FLICKR, NIAID

Children who have developed dengue immunity from a previous infection appear to be protected from getting sick from Zika, according to a study published yesterday (January 22) in PLOS Medicine.

The two viruses are closely related and the researchers reasoned that immunity to one may change susceptibility to the other.

The scientists looked at data from children collected from the 2016 Zika epidemic in Managua, Nicaragua. They followed roughly 3,700 children between two and 14 years old, focusing on those whose history with dengue was known.

Kids who previously had dengue were 38 percent less likely to show Zika symptoms when infected than those who hadn’t had dengue, Scientific American reports. “It didn’t protect them from getting infected, but if they got infected, they were less likely to get sick,” study coauthor Aubree Gordon of the University of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Carolyn Wilke

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development